The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol “Cables1” is ambiguous in the literature, and literature is very limited for this specific protein. The target here is specifically Drosophila melanogaster CG6191/Cables1, FlyBase FBgn0027581, UniProt A0A0B4KF19—not human or mouse CABLES1 (“CDK5 and ABL1 enzyme substrate 1”). Exact searches using the accession, FlyBase identifier, CG number, and fly aliases did not recover a primary study establishing the molecular function of this exact protein.
Accordingly, the defensible annotation is narrow: A0A0B4KF19 is a predicted CABLES1/2-family cyclin-like protein containing a Cyclin N-terminal domain. It is most plausibly a non-enzymatic protein-interaction/adaptor protein, but its partners, pathway, biological role, phenotype, and intracellular localization have not been experimentally established for CG6191. Mammalian CABLES1 biology is useful only for hypothesis generation and must not be presented as evidence about the fly protein.
The supplied UniProt record consistently identifies the target as:
These identifiers and domain calls are internally coherent: the protein is a fly CG6191 gene product assigned to the CABLES1/2 branch of cyclin-fold proteins. However, the annotation evidence codes supplied with the record indicate computational/domain or imported database support rather than a demonstrated biochemical function.
The literature retrieved under “CABLES1” overwhelmingly concerns mammalian CABLES1. Reviews place mammalian CABLES1 among atypical cyclin-fold proteins and discuss its tumor-suppressive and regulatory activities, but they do not discuss Drosophila CG6191 (quandt2020atypicalcyclinsthe pages 2-4, mikolcevic2012orphankinasesturn pages 2-3, quandt2020atypicalcyclinsthe pages 4-7). This species distinction is decisive.
A cyclin N-terminal domain is principally a folded protein-interaction module. Its presence does not imply that the protein catalyzes a reaction. Conventional cyclins regulate CDKs through binding, whereas “atypical cyclins” are cyclin-box-containing proteins whose interactions and functions can differ substantially from classical cell-cycle cyclins. A contemporary review uses structural features, interactors, and phylogeny—not merely cyclic expression—to classify atypical cyclins (publication: August 2020; DOI) (quandt2020atypicalcyclinsthe pages 2-4).
For mammalian CABLES1, authoritative reviews characterize the protein as cyclin-fold-containing but unlikely to function as a conventional CDK activator. Mammalian CABLES1 can bind CDK17/PCTK2, yet did not stimulate that kinase’s activity in vitro (publication: August 2012; DOI) (mikolcevic2012orphankinasesturn pages 2-3). This supports the family-level hypothesis that fly CG6191 is an interaction scaffold or regulatory adaptor rather than an enzyme, but it does not demonstrate that role in flies.
No evidence was found that A0A0B4KF19 possesses catalytic activity. Therefore:
It would be inappropriate to annotate CG6191 as a kinase merely because mammalian CABLES1 interacts with kinases. CABLES proteins are kinase-associated proteins, not themselves established protein kinases.
| Annotation question | Conclusion for this exact fly protein | Evidence level | Important caveat |
|---|---|---|---|
| Identity / organism | A0A0B4KF19 corresponds to Cables1/CG6191 (FBgn0027581) from Drosophila melanogaster, based on the supplied UniProt metadata. | Moderate—database annotation | The record uses evidence codes associated with imported records and sequence-based prediction; exact-identifier literature searches found no direct publication independently validating this protein’s identity or function. |
| Domain-family classification | Annotated as a CABLES1/2-family, cyclin-like protein containing a Cyclin N-terminal domain (PF00134/IPR006671) and belonging to the cyclin family. | Moderate—profile/domain inference | The domain assignment supports evolutionary and structural similarity, not canonical cyclin activity. Reviews describe mammalian CABLES1 as an atypical cyclin-fold protein unlikely to act as a conventional CDK activator, but that is not direct evidence for fly CG6191 (quandt2020atypicalcyclinsthe pages 2-4, mikolcevic2012orphankinasesturn pages 2-3). |
| Catalytic function | No catalytic reaction, substrate, cofactor, or enzymatic activity has been established. The best-supported provisional interpretation is a non-enzymatic cyclin-like interaction or adaptor protein. | Very low / unknown | A cyclin domain is a protein-interaction fold and does not itself establish catalysis. Mammalian CABLES1 data cannot demonstrate the biochemical activity of CG6191. |
| Molecular partners | No experimentally validated binding partner was found for CG6191. | No direct evidence | Mammalian CABLES1 interacts with CDKs and other regulatory proteins, but even some mammalian interactions do not activate kinase activity; these observations must remain comparative hypotheses rather than fly annotations (mikolcevic2012orphankinasesturn pages 2-3, quandt2020atypicalcyclinsthe pages 4-7). |
| Biological pathway | No pathway assignment is experimentally established for this exact fly protein. CDK-related, Abl-related, Wnt/β-catenin, p21/p63, and Slit–Robo roles are hypotheses requiring fly-specific testing. | No direct evidence | Retrieved Wnt/β-catenin, apoptosis, proteostasis, and tumor-suppressor evidence concerns mammalian CABLES1 or mouse models, not Drosophila CG6191 (quandt2020atypicalcyclinsthe pages 2-4, quandt2020atypicalcyclinsthe pages 9-10, quandt2020atypicalcyclinsthe pages 4-7). |
| Subcellular localization | Unknown. No validated nuclear, cytoplasmic, membrane, organellar, or extracellular localization was found. | No direct evidence | Localization should not be inferred solely from the cyclin-like domain or from mammalian CABLES1 studies. |
| Phenotype | No precise loss-of-function, gain-of-function, developmental, behavioral, fertility, or viability phenotype was found for CG6191. | No direct evidence | Mammalian tumor progression, apoptosis, and growth phenotypes concern a different species and cannot be assigned to this fly gene (quandt2020atypicalcyclinsthe pages 2-4, quandt2020atypicalcyclinsthe pages 4-7). |
| Recent 2023–2024 literature | Exact searches for A0A0B4KF19, CG6191, and FBgn0027581 found no directly relevant 2023–2024 study. | Evidence gap | Recent papers discussing CABLES1 generally address mammalian biology or broad cyclin evolution; recency does not overcome species mismatch. |
| Applications | No current biotechnology, therapeutic, diagnostic, agricultural, or other real-world application is established for this exact protein. Its present value is primarily as an uncharacterized target for functional genomics. | No direct evidence | Human CABLES1 cancer research is not an application of Drosophila CG6191 and should not be presented as such (quandt2020atypicalcyclinsthe pages 2-4, quandt2020atypicalcyclinsthe pages 9-10). |
Table: Evidence assessment for the exact Drosophila melanogaster protein A0A0B4KF19. It separates database-supported identity and domain classification from unsupported functional transfer based on mammalian CABLES1.
No retrieved primary paper established a loss-of-function phenotype, rescue phenotype, biochemical activity, physical interaction, or defined biological process for Drosophila CG6191. Thus, assigning it to cell-cycle control, axon guidance, apoptosis, adhesion, Wnt signaling, or proteostasis would presently exceed the available fly-specific evidence.
The most conservative functional statement is:
CG6191 encodes a predicted CABLES-family cyclin-like protein whose cyclin fold suggests a protein-binding regulatory role; its physiological interaction partners and primary biological function in D. melanogaster remain unknown.
Mammalian CABLES1 has been investigated as a regulatory adaptor and tumor suppressor. Reported mammalian activities include interactions with CDKs, stabilization of p21, protection of p63 from proteasomal degradation after genotoxic stress, promotion of apoptosis when overexpressed, and modulation of tumor progression and Wnt/β-catenin signaling in mouse models (publication: August 2020; DOI) (quandt2020atypicalcyclinsthe pages 2-4, quandt2020atypicalcyclinsthe pages 9-10, quandt2020atypicalcyclinsthe pages 4-7).
These observations suggest testable possibilities for CG6191—CDK association, regulation of protein stability, or integration of growth and stress signaling—but none should enter a fly functional annotation without orthology validation and direct experiments. Even in mammalian systems, reviews note that the functional significance of several CABLES1–CDK interactions remains insufficiently resolved (quandt2020atypicalcyclinsthe pages 4-7).
No signaling or biochemical pathway is experimentally assigned to A0A0B4KF19 in the retrieved literature.
Candidate pathways inferred from mammalian CABLES1 include CDK-associated regulation, Abl-linked signaling, Wnt/β-catenin regulation, cell-cycle restraint, apoptosis, and proteasomal control of p21/p63. These are comparative candidates, not validated pathways for CG6191. Mammalian CABLES1 loss enhanced intestinal tumor progression in an Apc mutant mouse model, potentially through elevated Wnt/β-catenin signaling; this is mouse cancer evidence and cannot be transferred directly to fly CG6191 (quandt2020atypicalcyclinsthe pages 2-4, quandt2020atypicalcyclinsthe pages 4-7).
Likewise, the expanded name “CDK5 and ABL1 enzyme substrate 1” derives from mammalian CABLES1 literature. It does not establish that the fly protein is a substrate of Drosophila Cdk5 or Abl.
The localization of the exact fly protein is unknown. No validated microscopy, biochemical fractionation, organelle-proteomics, secretion, or membrane-topology evidence was found.
The available domain information does not by itself predict a unique compartment. A soluble intracellular localization is plausible for a cyclin-fold regulatory protein, but even the distinction between nuclear and cytoplasmic function requires experiment. No extracellular, transmembrane, or organelle-specific role should be assigned from the current evidence.
Recommended localization experiments are endogenous fluorescent tagging followed by live imaging across developmental stages, nuclear–cytoplasmic fractionation, and colocalization with candidate CDKs or Abl. Endogenous tagging is preferable to overexpression because adaptor localization can depend on stoichiometric interactions.
Exact searches for A0A0B4KF19, FBgn0027581, and CG6191 recovered no directly relevant 2023–2024 functional study. Consequently, there is no recent fly-specific advance to report without conflating this target with mammalian CABLES1 or unrelated uses of the word “cables.”
No therapeutic, diagnostic, biotechnology, agricultural, or other real-world application was found for Drosophila CG6191. Human CABLES1 cancer studies are not applications of the fly protein. At present, CG6191's practical value is as an uncharacterized functional-genomics target whose investigation could test the evolutionary conservation of CABLES-family mechanisms.
No quantitative fly-specific measurements—such as enzymatic constants, binding affinities, penetrance, survival effects, expression fold changes, or localization percentages—were found. The principal quantitative result of the present search is therefore an evidence gap: zero directly relevant papers were recovered under the exact accession, FlyBase ID, or CG6191 identifier in the searched corpus. This should not be interpreted as proof that no data exist anywhere, but it indicates that no robust publication-level annotation could be substantiated.
A suitable current annotation is:
Predicted non-enzymatic CABLES1/2-family cyclin-like protein. Contains a Cyclin_N/cyclin-like fold likely mediating protein interactions. Molecular partners, pathway, subcellular localization, and organismal function in Drosophila melanogaster are undetermined.
The highest-value experiments would be:
The identity and domain architecture supplied for A0A0B4KF19 are consistent with a D. melanogaster CABLES-family cyclin-like protein. The literature, however, does not currently support a precise fly-specific function, pathway, localization, substrate, or phenotype. The extensive mammalian CABLES1 literature concerns a different organism and must remain comparative. Therefore, the primary function of CG6191 should be recorded as unknown, with a provisional inference of a non-catalytic cyclin-fold interaction/adaptor role rather than a canonical cyclin or enzyme.
References
(quandt2020atypicalcyclinsthe pages 2-4): Eva Quandt, Mariana P. C. Ribeiro, and Josep Clotet. Atypical cyclins: the extended family portrait. Cellular and Molecular Life Sciences: CMLS, 77:231-242, Aug 2020. URL: https://doi.org/10.1007/s00018-019-03262-7, doi:10.1007/s00018-019-03262-7. This article has 61 citations.
(mikolcevic2012orphankinasesturn pages 2-3): Petra Mikolcevic, Johannes Rainer, and Stephan Geley. Orphan kinases turn eccentric. Cell Cycle, 11:3758-3768, Aug 2012. URL: https://doi.org/10.4161/cc.21592, doi:10.4161/cc.21592. This article has 71 citations and is from a peer-reviewed journal.
(quandt2020atypicalcyclinsthe pages 4-7): Eva Quandt, Mariana P. C. Ribeiro, and Josep Clotet. Atypical cyclins: the extended family portrait. Cellular and Molecular Life Sciences: CMLS, 77:231-242, Aug 2020. URL: https://doi.org/10.1007/s00018-019-03262-7, doi:10.1007/s00018-019-03262-7. This article has 61 citations.
(quandt2020atypicalcyclinsthe pages 9-10): Eva Quandt, Mariana P. C. Ribeiro, and Josep Clotet. Atypical cyclins: the extended family portrait. Cellular and Molecular Life Sciences: CMLS, 77:231-242, Aug 2020. URL: https://doi.org/10.1007/s00018-019-03262-7, doi:10.1007/s00018-019-03262-7. This article has 61 citations.